SCHRODER INVESTMENT MANAGEMENT GROUP - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 214 filers reported holding SAGE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.

Quarter-by-quarter ownership
SCHRODER INVESTMENT MANAGEMENT GROUP ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,071,724
-84.8%
52,076
-65.4%
0.00%
-80.0%
Q2 2023$7,067,294
+212.3%
150,304
+178.7%
0.01%
+233.3%
Q1 2023$2,262,735
+3.4%
53,926
-6.0%
0.00%0.0%
Q4 2022$2,188,702
+36378.4%
57,386
+40030.1%
0.00%
Q4 2021$6,000
+50.0%
143
+70.2%
0.00%
Q3 2021$4,000
-20.0%
840.0%0.00%
Q2 2021$5,000
-99.8%
84
-99.7%
0.00%
-100.0%
Q1 2021$2,275,000
-83.8%
30,399
-81.3%
0.00%
-70.0%
Q4 2020$14,086,000
+220.9%
162,830
+116.6%
0.01%
+42.9%
Q3 2020$4,390,000
+74.3%
75,164
+24.1%
0.01%
+40.0%
Q2 2020$2,518,000
+312.8%
60,553
+181.5%
0.01%
+400.0%
Q1 2020$610,000
+244.6%
21,508
+1635.9%
0.00%
Q3 2019$177,000
+15.7%
1,239
+48.0%
0.00%
Q2 2019$153,000
-52.3%
837
-58.6%
0.00%
-100.0%
Q1 2019$321,000
+26.4%
2,020
-23.8%
0.00%
Q4 2018$254,000
-35.9%
2,650
-5.4%
0.00%
-100.0%
Q3 2018$396,000
+9.7%
2,801
+17.9%
0.00%0.0%
Q2 2018$361,0002,3750.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Integral Health Asset Management, LLC 409,000$17,399,0004.82%
Palo Alto Investors LP 781,730$33,255,0002.12%
DAFNA Capital Management LLC 180,306$7,670,0001.93%
Boxer Capital, LLC 1,094,000$46,539,0001.81%
Deep Track Capital, LP 500,000$21,270,0001.50%
Bellevue Group AG 3,228,004$137,319,0001.42%
EcoR1 Capital, LLC 940,636$40,015,0001.28%
Deep Track Capital, LP 400,000$17,016,0001.20%
Artal Group S.A. 1,000,000$42,540,0001.15%
SECTOR GAMMA AS 98,904$4,207,0000.99%
View complete list of SAGE THERAPEUTICS INC shareholders